- Home
- About
- Find staff
- Leif Klint
Leif Klint
-
Risk Factors for Developing Brain Metastasis for Patients with HER2-Positive Breast
Cancer
Leif Klint, Aniko Kovács, Barbro Linderholm
Annals of Medical and Clinical Oncology - 2024 -
Metronomic chemotherapy using capecitabine and cyclophosphamide in metastatic breast cancer - efficacy, tolerability and quality of life results from the phase II METRO
trial
Karolina Larsson, Jamila Adra, Leif Klint, Barbro Linderholm
BREAST - 2024 -
Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2
trial
Knut Jorgen Labori, Svein-Olav Bratlie, Bodil Andersson, Jon-Helge Angelsen, Christina Biörserud, Bergthor Bjornsson, Erling Audun Bringeland, Nils Elander, Herish Garresori, Jon Erik Gronbech, Johan Haux, Oskar Hemmingsson, Maria Gustafsson Liljefors, Tor Age Myklebust, Linn Save Nymo, Katriina Peltola, Per Pfeiffer, Ville Sallinen, Per Sandstrom, Ernesto Sparrelid, Helge Stenvold, Kjetil Soreide, Bobby Tingstedt, Caroline Verbeke, Daniel Ohlund, Leif Klint, Svein Dueland, Kristoffer Lassen
LANCET GASTROENTEROLOGY & HEPATOLOGY - 2024 -
Real world data on adjuvant treatment of older HER2-positive breast cancer patients – A single institution experience through 8
years
Leif Klint, A. Kovács, Elisabeth Werner Rönnerman, Barbro Linderholm
Cancer Treatment and Research Communications - 2021